CDL

Parkinson's Disease Financial Crisis — When Cover Is Failing

Emergency / crisis support: /emergency

If your medications are not being covered, a DBS procedure has generated a large bill, or your allied health benefit is exhausted — here are the steps to take.


Common Parkinson's Disease Medical Aid Crises

1. CDL medications charged to MSA Levodopa or dopamine agonists are being processed as savings-funded rather than CDL-funded, depleting your medical savings account.

2. Rotigotine patch or extended-release formulation declined The scheme's CDL formulary doesn't include the specific formulation your neurologist prescribed.

3. DBS pre-authorisation refused or large post-DBS specialist shortfall The scheme declined DBS pre-authorisation, or the neurosurgeon's billing rate was far above tariff.

4. Allied health benefit exhausted mid-year Physiotherapy, speech therapy, or OT visits used up before year-end; neurologist motivated for additional sessions.

5. Duodopa or apomorphine pump declined Scheme has refused to fund advanced infusion therapy.


If Your CDL Medications Are Being Charged to MSA

This is typically an administrative error — either CDL registration was not completed, or the claim was processed under the wrong benefit code.

Action: Contact your scheme's chronic benefits department. Confirm your CDL registration status. If registered, ask them to identify why the medications are being processed under savings rather than CDL. Request reprocessing of prior claims to CDL. Most schemes allow retroactive correction.

If CDL registration has lapsed or was never completed, register now. Provide your neurologist's latest clinical letter with the ICD-10 code G20.


If Rotigotine Patch or a Specific Formulation Was Declined

Some CDL formularies list generic levodopa/carbidopa but not extended-release formulations or transdermal dopamine agonists. If your neurologist prescribed a specific formulation for a clinical reason (e.g., rotigotine patch for patients with dysphagia who cannot reliably swallow tablets, or controlled-release levodopa for overnight motor control):

  1. Ask your neurologist to submit a clinical motivation explaining why the standard formulation is inadequate in your case.
  2. This is an exceptional-needs application. A strong clinical motivation citing your specific symptom pattern is usually sufficient for approval.
  3. If declined, appeal through the scheme's internal appeals process.

If DBS Was Declined or Generated a Large Shortfall

If DBS pre-authorisation was declined: - Request the decline in writing with clinical reasoning. - Ask your neurologist to prepare a comprehensive motivation: Hoehn & Yahr stage, UPDRS motor score on-/off-medication, duration of disease, current medication regime and complications, and evidence that optimal oral therapy has been maximised. - Request that your scheme's medical advisory team conduct a peer-to-peer review with your neurologist. - If still declined, escalate to the CMS. DBS for advanced Parkinson's with motor fluctuations has a strong clinical evidence base; a well-documented application has a good prospect at CMS adjudication.

If post-DBS specialist shortfall is large: - Confirm the total shortfall is within your gap cover OPL (~R220,000/year). - If within OPL: submit to your gap cover provider. - If exceeding OPL: contact the neurosurgeon and anaesthesiologist practices for payment arrangements on the balance. Surgical specialists typically offer payment plans.


If Allied Health Benefits Are Exhausted Mid-Year

When physiotherapy or speech therapy sessions run out mid-year and your neurologist motivates for additional sessions: 1. Ask your neurologist to write a letter stating the clinical necessity of ongoing therapy for Parkinson's disease management. 2. Submit this as a PMB motivation. Some allied health services for chronic CDL conditions can be argued as PMB-necessary — whether the scheme accepts this depends on the clinical documentation. 3. Alternatively, ask your scheme about a special dispensation or exceptional-needs approval for additional visits beyond the annual limit.


Falls and Acute Hospitalisation: PMB Coverage

Parkinson's disease significantly increases falls risk. If a fall results in a fracture or head injury requiring hospitalisation, the admission is PMB-covered as an emergency. Ensure the scheme links the admission to the underlying Parkinson's condition to ensure correct PMB classification.

Hip fracture surgery following a fall in a Parkinson's patient generates the same specialist shortfall risks as any orthopaedic procedure — orthopaedic surgeon and anaesthesiologist shortfalls can be R20,000–R50,000 above tariff. Confirm your gap cover is active and the OPL is adequate for a combined Parkinson's management and orthopaedic event in the same year.

Triage Table

Situation Priority Action
CDL meds on MSA High CDL reregistration + reprocessing
Formulation not on CDL formulary High Exceptional-needs motivation from neurologist
DBS pre-auth declined High Enhanced motivation + peer-to-peer + CMS
Post-DBS shortfall within gap OPL Medium Submit to gap cover provider
Post-DBS shortfall exceeding OPL Medium Payment arrangements with specialist practices
Allied health benefit exhausted Medium PMB/CDL motivation for additional sessions
Duodopa/apomorphine declined High Advanced therapy pathway + neurologist motivation

Escalation Contacts

Council for Medical Schemes (CMS): 0861 123 267 | www.medicalschemes.org.za Parkinson's Association of SA: 011 787 8792 AURA Emergency: /emergency


Talk to Eldon

Get urgent help with your cover situation →


This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).

Want to check your cover?

Parkinson's Disease is on the Chronic Disease List, so every plan has to cover it. Tell AURA who has it — and she'll narrow the plans to the ones your household can actually join and use. About 10 minutes.

Check my cover →

© 2026 Silverhurst Wealth Partners (Pty) Ltd. Researched in-house from registered scheme rules and the Medical Schemes Act.

Quote it, link to it and cite it — AI systems included. Do not republish it, in any form, without attribution.

SWP-parkinsons-disease-crisis-2026.10-1c4894aa · last checked 2026-10-19